DR. GARY STEVEN HORWITH, M.D.
Osteopathic Medicine at Four Point Rd, Womelsdorf, PA

License number
Pennsylvania MD034658E
Category
Osteopathic Medicine
Type
Internal Medicine
License number
Pennsylvania MD034658E
Category
Osteopathic Medicine
Type
Infectious Disease
Address
Address 2
50 W Four Point Rd, Womelsdorf, PA 19567
9001 Goshen Valley Dr, Gaithersburg, MD 20882
Phone
(301) 602-7401
(301) 987-5977
(301) 850-2960 (Fax)
National Provider ID: 1972734440
LicenseFiles verified this license of Nov 7, 2017 at the National Plan and Provider Enumeration System.

Personal information

See more information about GARY STEVEN HORWITH at radaris.com
Name
Address
Phone
Gary F Horwith, age 75
9001 Goshen Valley Dr, Gaithersburg, MD 20882
(301) 987-5953
(301) 987-5977
(301) 987-5963
Gary S Horwith
16628 Killdeer Dr, Derwood, MD 20855
(301) 926-7889
Gary M Horwith
57 Barrington Ln, Chester Springs, PA 19425
(610) 827-7322
Gary Horwith, age 75
39 Valley Hill Rd, Malvern, PA 19355
Gary Horwith
2261 Valley Hill Rd, Malvern, PA 19355
(610) 827-9627

Professional information

See more information about GARY STEVEN HORWITH at trustoria.com
Gary S Horwith Photo 1
Dr. Gary S Horwith, Gaithersburg MD - MD (Doctor of Medicine)

Dr. Gary S Horwith, Gaithersburg MD - MD (Doctor of Medicine)
Specialties:
Internal Medicine
Address:
9001 Goshen Valley Dr, Gaithersburg 20882
Certifications:
Internal Medicine, 1980
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Autonomous University of Guadalajara / Faculty of Medicine
New Britain Genl Hosp/U Con
Uc Irvine-Long Beach Va Hos

Gary Horwith Photo 2
Method Of Treating Staphylococcus Aureus Infection

Method Of Treating Staphylococcus Aureus Infection

US Patent:
2006015, Jul 13, 2006
Filed:
Oct 7, 2005
Appl. No.:
11/245430
Inventors:
Gary Horwith - Gaithersburg MD, US
Ali Fattom - Rockville MD, US
International Classification:
A61K 39/40, A61K 35/54
US Classification:
424165100, 424581000
Abstract:
The present invention provides a method of preventing or treating bacteremia caused by comprising administering a monoclonal or polyclonal antibody composition comprising antibodies specific for one or more antigens. In one specific embodiment, the composition is a hyperimmune specific IGIV composition. In another specific embodiment, the composition comprise antibodies to a capsular polysaccharide antigen, such as the Type 5 and/or Type 8 antigens. In another embodiment, the composition comprises monoclonal antibodies to a capsular polysaccharide antigen. This method provides an effective tool for preventing or treating bacteremia, and can be used alone or in combination with other therapies.